Short read synopsis:

Infection control in air ambulance and HEMS operations is no longer a narrow clinical procedure applied after a mission; it is a defining feature of safe, resilient and mission-ready aeromedical care. This article explores why aircraft present a uniquely demanding environment for infection prevention, where confined cabins, certified interiors, mixed clinical and flight crew spaces, and rapid turnaround expectations all shape what is practically achievable. It considers the clinical risks associated with infectious patients, aerosol-generating procedures, complex transfers and high-touch equipment, while also examining the operational consequences of cleaning, decontamination and aircraft downtime.

Crucially, it highlights the tension between NHS infection-control expectations and the aircraft manufacturer limitations that govern which materials, products and methods can be safely used. The article then looks beyond PPE and cleaning alone, arguing that the future of infection resilience lies in better aircraft design, improved cabin layouts, ventilation, HEPA filtration, sealed flooring, separation of clinical and cockpit areas, and robust assurance processes. For air ambulance providers, infection control must now be designed in, not added on.

Introduction

Air ambulance and Helicopter Emergency Medical Services (HEMS) operate at the intersection of urgent clinical care, aviation safety and highly constrained aircraft environments. Infection prevention and control (IP&C) is therefore not simply a healthcare discipline transferred into an aircraft; it is a specialist operational challenge that must reconcile NHS clinical expectations, aviation regulation, aircraft certification, manufacturer limitations and the need to preserve emergency availability. The COVID-19 pandemic exposed how quickly infectious risk can affect air ambulance operations, but the requirement is broader and enduring: every mission must protect the patient, clinical crew, flight crew and the next patient who will use the aircraft.

The operational challenge

The primary challenge is the aircraft itself. Unlike a hospital treatment room or modern road ambulance, many air ambulance platforms began life as multi-role aircraft and were subsequently adapted for aeromedical work. Cabins are narrow, curved, weight-sensitive and filled with certified equipment, seat tracks, oxygen systems, avionics, furnishings and stowage. Patients, clinicians and flight crew may share the same pressure vessel, and in some aircraft the opportunity to create physical separation between cockpit and clinical areas is limited. Reduced cabin volume can increase concern around droplet and airborne transmission, although this may be mitigated by ventilation performance, air replacement cycles and filtration where installed.

Downtime is equally important. After a routine low-risk transfer, cleaning and disinfection may be completed as part of normal turnaround, often while ground transfer activity is taking place. By contrast, a suspected or confirmed infectious-risk transfer may trigger a formal deep clean, requiring trained personnel, approved products, waste disposal, appropriate drying or dwell time, and confirmation that the aircraft is safe to return to service. Depending on the pathogen, degree of contamination and cleaning method required, downtime can vary significantly.

Clinical concerns

Clinical risk identification begins with patient information and clinical assessment. Air ambulance teams may be asked to move patients with known infection, undiagnosed fever, respiratory symptoms, multi-drug-resistant organisms, body-fluid contamination, immunosuppression or complex wounds. The clinical crew must make rapid decisions on personal protective equipment, patient placement, airway management, waste control and equipment protection. Aerosol-generating procedures, suction, ventilation circuit breaks and emergency airway interventions all increase risk and complexity, particularly in a confined cabin environment where clinicians cannot freely reposition themselves around the patient.

The patient population also matters. Bariatric patients, neonatal cases, paediatric transfers, maternity missions, extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pump (IABP) transfers all bring additional equipment and handling requirements. More equipment means more high-touch surfaces, more power and gas interfaces, and more items that may require cleaning or isolation after the mission.

Cleaning products and the OEM constraint

Healthcare guidance rightly emphasises effective environmental cleaning, safe management of care equipment, hand hygiene, PPE and transmission-based precautions. However, aircraft cleaning cannot be determined by healthcare preference alone. Cleaning agents must also be compatible with aircraft structures, windows, seals, upholstery, flooring, avionics, placards, oxygen equipment and certified medical interiors. A disinfectant commonly advised in a healthcare setting may not be acceptable for repeated use on aircraft materials if it causes corrosion, crazing, degradation of plastics, loss of fire-retardant performance, damage to markings or deterioration of certified components.

This creates a genuine compliance tension. NHS standard advice may specify the desired infection-control outcome, while the aircraft original equipment manufacturer (OEM), interior supplier or supplemental type certificate holder may restrict the substances, concentrations or application methods that can be used. Operators must therefore maintain an approved cleaning matrix that satisfies clinical governance without compromising airworthiness. Where conflict exists, it should be resolved through risk assessment, clinical sign-off, engineering review and, where necessary, OEM no technical objection (“NTO”) or approved modification data. All of this takes in an environment where patient and crew safety remains paramount.

Controls: PPE, environment and engineering

The strongest approach follows the hierarchy of controls. PPE remains essential, especially for loading, close patient contact, aerosol risk and post-mission cleaning. Correct donning and doffing, respiratory protection where indicated, eye protection, gloves, gowns or coveralls, and clear waste segregation all reduce exposure. However, PPE should not be the only control. Administrative controls such as pre-task infection-risk screening, defined hot/warm/cold zones, documented cleaning records, monthly hygiene assurance checks, staff training and rapid escalation to specialist decontamination providers are equally important.

Environmental and engineering controls are increasingly shaping the next generation of aeromedical interiors. These include sealed or easily cleanable flooring, removable or wipeable equipment mounts, protected stowage, dedicated sharps and waste provision, improved cabin airflow, HEPA filtration, cockpit-clinical physical barriers, and layouts that reduce unnecessary touchpoints. Physical separation of flight crew and clinical teams is particularly valuable when infectious patients are carried, provided it does not compromise emergency egress, crashworthiness, crew resource management or aviation regulatory compliance.

Gama Aviation’s future-facing approach

Gama Aviation’s developing approach recognises that infection control, risk reduction, patient equality and aircraft utility are connected. Its air ambulance work combines clinical input, design capability and operational experience to create aircraft that are easier to clean, easier to re-role and better suited to future patient demographics. Within fixed-wing developments such as the King Air, Gama Aviation has focused on improved cabin layout, increased clinical space, independent ground-use power, support for advanced clinical missions, enhanced ventilation, HEPA filtration, sealed flooring and separation between flight and clinical teams. These measures are intended to reduce infection risk while improving operational resilience and patient care.

In rotary-wing environments, Gama Aviation’s H145 and AW169 developments demonstrate a similar direction of travel. Modifications include bariatric stretcher position adaptors, toolless incubator adaptations, alternate ground-use battery power for clinical systems, cabin airflow support, provision for sharps and waste bins, and cockpit/cabin partition concepts for infectious-patient carriage. The use of protective films and materials with higher tolerance to approved cleaning agents supports the practical reality that an aircraft interior must withstand repeated disinfection throughout its operational life.

Conclusion

Infection control in air ambulance and HEMS operations is a complex balance of clinical best practice, aviation safety and operational availability. The sector cannot rely solely on PPE or post-mission cleaning; it must design infection resilience into aircraft interiors, procedures, training and engineering controls.

The future will belong to providers that can integrate NHS expectations with OEM-approved materials, certified modifications and mission-ready operating models. Gama Aviation’s work on ventilation, HEPA filtration, sealed flooring, cockpit separation demonstrates how infection control can become a design principle rather than an afterthought. In doing so, the air ambulance sector can ensure patient safety, protect crews, reduce downtime, improve equity of care and sustain high-availability critical care for the patients who need it most.